Advertisement
NEW YORK, May 29, 2017 /PRNewswire/ -- Read the full report: http://www.reportlinker.com/p04910441/Global-Blood-Banking-and-Blood-Products-Laboratory-Equipment-and-Supplies.htmlThe report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 209 companies including many key and niche players such as
- AABB - Americas Blood Centers - American Red Cross - Canadian Blood Services Read the full report: http://www.reportlinker.com/p04910441/Global-Blood-Banking-and-Blood-Products-Laboratory-Equipment-and-Supplies.htmlI. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting LimitationsDisclaimersData Interpretation & Reporting LevelQuantitative Techniques & AnalyticsProduct Definitions and Scope of StudyBlood Components and Plasma ProductsWhole Blood & Cellular ComponentsWBCsRBCsPlateletsPlasma FractionsFresh Frozen PlasmaAlbumin FractionsFactor VIIIFactor IX and Factor IX ComplexFibrin/ThrombinEquipment, Blood Tests and ConsumablesAutomated Analyzers for Blood AnalysisBlood Test ConsumablesII. EXECUTIVE SUMMARY1. MARKET OVERVIEWPreludeBlood Transfusion Worldwide: A Kaleidoscope of Stark ContrastsSafety and Availability: The Core IssuesTable 1: Prevalence of Major Transfusion-transmitted Infections by Economic Group (2016): Percentage of HIV, HBV and HCV in High Income, Middle Income and Low Income Countries (includes corresponding Graph/Chart)Current and Future AnalysisAnalysis of World Blood Banking & Blood Products by Value SalesAnalysis by Geographic RegionAnalysis by Product Group/TypePlasma and Plasma Derivatives Continue to Dominate Blood Components MarketEquipment, Blood Tests & Other Consumables to Display Steady GrowthWorld Blood Components and Plasma Market AnalysisTable 2: World Recent Past, Current & Future Analysis for Blood Components and Plasma by Region/Country - US, Europe, Japan and Rest of World Markets Independently Analyzed with Annual Consumption in Thousand Units for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 3: World 8-Year Perspective for Blood Components and Plasma by Region/ Country - Percentage Breakdown of Volume Consumption for US, Europe, Japan, and Rest of World Markets for Years 2015, 2017 & 2022 (includes corresponding Graph/Chart)Red Blood Cells - A Key Blood ComponentTable 4: World Recent Past, Current & Future Analysis for Red Blood Cells by Region/Country - US, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Thousand Units for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 5: World 8-Year Perspective for Red Blood Cells by Region/Country - Percentage Breakdown of Volume Consumption for US, Europe, Japan, and Rest of World Markets for Years 2015, 2017 & 2022 (includes corresponding Graph/Chart)2. MARKET TRENDS & ISSUESBlood Plasma Demand Exceeds Supply: Self-Sufficiency is the New MantraTable 6: Worldwide Market for Plasma Derivative Products by Product Type (2014): Percentage Breakdown of Revenues for A1PI, Albumin, Coagulation Factor, Hyperimmunes, IVIG, Plasma Derived Factor VIII, Prothrombin Complex Concentrate, and Others (includes corresponding Graph/Chart)Higher Plasma Center Numbers Key to Secure Raw Material Supply, Costs Remain A BottleneckTable 7: Number of Plasma Centers in Operation in the US for Leading Players (includes corresponding Graph/Chart)Platelet Rich Plasma Therapy Market Scales New HeightsEvolution in Plasma Collection Technologies - Current Achievements and Way AheadDemand for Plasma Derivatives on the RiseImmunoglobulins to See Steady GrowthTable 8: Global Immunoglobulins Market by Segment (2017 & 2022): Percentage Breakdown of Market Value for Intravenous IG, Hyperimmunes and Subcutaneous IG (includes corresponding Graph/Chart)Table 9: World IVIG Consumption by Geographic Region (2016): Annual Consumption in Kilograms Per Million People for North America, Europe and Rest of World (includes corresponding Graph/Chart)Table 10: World Market for Immunoglobulins by Indication (2016): Percentage Breakdown of Market Value for CIPD< PI, Off-Label and Others (includes corresponding Graph/Chart)Increasing Awareness of PID and CIPD Disorders to Drive IVIg MarketIndications Addressed by Major Global IVIg ManufacturersTable 11: Comparative Costs between Plasma Protein Therapies and Artificially Synthesized Pharmaceuticals (includes corresponding Graph/Chart)Growing Affinity for Home Care Unlocks Opportunities for Home-based IVIg TherapyTable 12: Worldwide Home Healthcare Services Market by Type of Service (2015E & 2020P): Percentage Breakdown of Service Revenues for Infusion Therapy Services, Rehabilitation Services, Respiratory Therapy Services, Telemetry, and Unskilled Homecare (includes corresponding Graph/Chart)Unsuccessful Clinical Trials for Alzheimer's a major Setback for IVIg MarketNew Indications to Drive Demand for AlbuminTable 13: World Albumin Consumption by Geography (2016): Annual Consumption in Grams per Thousand People for Leading Ten Countries (includes corresponding Graph/Chart)Low Awareness Affects Apha1 MarketRecombinants Lead FVIII MarketRising Incidence of Cancer Drives Demand for Apheresis SystemsPrIME: An Innovative High-Yield Process to Address Supply DearthPresent State of Plasma Fractionating IndustryPlasma Fractionation Industry Concentrated in Developed CountriesPrIME Tackles the Issue of Currently Unprocessable PlasmaIndustry Grappling with Blood Safety & Availability IssuesNew Infections - A Continuous ThreatSynthetic Substitutes to Bridge Demand-Supply Gap in BloodAutologous Transfusion Gearing up for High GrowthOut-of-Hospital Transfusions: An Emerging PhenomenonAutomation Tapping into Blood MarketAutomation in Pre-Transfusion DiagnosticsPenetration of Automated Equipment in the Plasma MarketThe Red Blood Cell Collection OpportunityRobots in Blood BankingBlood Banks Switching from Manual to Automated Cooler ValidationAutomated Blood Processing Systems in Open Heart SurgeriesAutomated Systems in CancerCerus' INTERCEPT Blood System Set to See Wider AdoptionPooling: Economical HIV TestingBallooning Global Geriatric Populace to Drive Demand for Blood ProductsTable 14: Elderly Population (65+ Years) as a Percentage of the Total Population: 2014 & 2025 (includes corresponding Graph/Chart)Table 15: Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)Improving Healthcare Expenditure to Foster Growth of Blood Banking SectorTable 16: Healthcare Spending as % of GDP by Region (2016E) (includes corresponding Graph/Chart)Table 17: Global Intravenous Immunoglobulin Consumption in Kilograms per Million Residents for Select Countries (includes corresponding Graph/Chart)3. COMPETITIVE LANDSCAPELeaders in Global Blood Plasma Ramp Up Market ShareTable 18: Leading Players in the Global Plasma Market (2016): Percentage Breakdown of Market Value for CSL, Grifols, Octapharma, Shire and Others (includes corresponding Graph/Chart)Grifols - A Fast Emerging PlayerTable 19: Plasma Fractionation Production Capacity of Grifols by Location: 2011 & 2015 (In Million Liters) (includes corresponding Graph/Chart)Table 20: Leading Players in Plasma Fractionation by Capacity (2017 & 2022): Percentage Breakdown of Annual Capacity for CSL, Grifols, Kedrion, Octapharma, Shire and Others (includes corresponding Graph/Chart)Grifols Loses Grip on IG Market, Pins Hopes on New ProductIVIg - A Highly Consolidated MarketTable 21: Leading Players in the Global Immunoglobulin Market (2016E): Percentage Breakdown of Market Value for CSL, Grifols, Octapharma, Shire and Others (includes corresponding Graph/Chart)Table 22: Global Market for Immunoglobulin (IVIg and SCIg) by Leading Players (2014): Percentage Breakdown of Value Sales for Baxter, CSL, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart)Table 23: Global Subcutaneous Immunoglobulin Market by Leading Player (2014): Percentage Market Share Breakdown of Revenue for Baxter, CSL, and Grifols (includes corresponding Graph/Chart)Big Three Corner Majority of Blood Collection Systems MarketTable 24: Global Whole Blood Collection Systems Market (2015E): Percentage Breakdown of Value Sales for Fresenius/Fenwal, Haemonetics, MacoPharma, Terumo, WEGO, and Others (includes corresponding Graph/Chart)Table 25: Global Apheresis Systems Market (2015E): Percentage Breakdown of Value Sales for Fresenius/Fenwal, Haemonetics, Terumo, and Others (includes corresponding Graph/Chart)Other Key StatisticsTable 26: Leading Players in the Global Albumin Market (2016E): Percentage Breakdown of Market Value for CSL, Grifols, Octapharma, Shire and Others (includes corresponding Graph/Chart)Table 27: Leading Players in the Global Alpha1 Market (2016E): Percentage Breakdown of Market Value for CSL, Grifols and Others (includes corresponding Graph/Chart)Grifols and Others (includes corresponding Graph/Chart 4. PRODUCT OVERVIEWBlood Banking and Blood Products IndustryBlood Components and Plasma ProductsEquipment, Blood Tests and ConsumablesEquipmentAutomated Analyzers for Blood AnalysisBlood Collection EquipmentBlood Collection MonitorsBlood Donor CouchesBlood Processing EquipmentBlood Bank CentrifugesPlasma ThawingBlood Cell SeparatorsBlood Storage EquipmentBlood BagsPlatelet AgitatorsBlood Bank RefrigeratorsBlood TestsConsumablesBlood - A PrimerIonic StructureBlood Components and their ApplicationsBlood ConstituentsPlasmaRed Blood Cells (RBC)Blood CountPlateletsWhite Blood Cells (WBC)Derivative Products of Blood or Plasma FractionsAlbumin FractionsImmunoglobulinsHyper-Immune ImmunoglobulinFactor VIIIFactor IX and Factor IX ComplexFibrin/ThrombinConsumption of Blood Based on Type of Surgery/Accident (In Units)Recombinant ProductsBlood Plasma SourcingTable 29: Global Plasma Derivatives Market: Percentage Breakdown of Costs Associated with Production (includes corresponding Graph/Chart)Plasma Protein and FractionationPlasma Fractionation: Origins and DevelopmentTable 30: Plasma Fractionation Processes: Comparison of Cohn IVIG and PrIME IVIG Based on Specific CharacteristicsThe NeedFresh Frozen PlasmaOther Plasma FractionsIVIGFactor VIIIAlbuminTherapeutic Uses of Plasma ProductsAlbumin ProductsImmunoglobulinsIntravenous Immunoglobulin (IVIg)Normal Immunoglobulin (IMIg)CMV ImmunoglobulinHepatitis B ImmunoglobulinRh (D) ImmunoglobulinTetanus Immunoglobulin IMZoster ImmunoglobulinPlasma Derived Coagulant ProductsBiostate®Ceprotin®Factor VII ConcentrateFactor XI ConcentratesFeiba VH® Inhibitor TreatmentFibrogammin P®Monofix®-VFProthrombinexTM-HTThrombotrol®-VF5. BLOOD COLLECTION METHODSBanking the Natural Blood ResourcesBlood BanksBlood BankingBlood TransfusionRole of Blood BanksBlood Donor: The Epicenter of the ProcessEligibility Criteria for the DonorThe Basics of Blood Donation - Myths & FactsTable 31: Active Donors of Whole Blood and Apheresis per 1,000 of Population by Country/ Agency (includes corresponding Graph/Chart)Table 32: Percentage Breakdown of Apheresis and Whole Blood Donations by Country (includes corresponding Graph/Chart)Collection MethodsBlood Donation: The ProcessTypes of Blood DonationDirected Blood DonationsAutologous Blood DonationAlternative Usage of Patient's Own BloodGeneral Blood DonationHemodilutionWound DrainageCell SaverThe MethodBlood SalvagingBlood Collection CentersBlood Collection Management SystemA Historical RetrospectiveBlood Collection CentersTypes of Blood Collection CentersCord Blood BanksProfit Collection CentersMilitary Blood BanksHospital Blood BanksCommunity Blood BanksNon-Profit Collection CentersBlood ProcessingBlood TypingRh Blood Group SystemABO Blood Group SystemBlood Types and their CompatibilityTable 33: Occurrence of Blood Groups Worldwide (In %) ( includes corresponding Graph/Chart)Blood TestBlood CultureThe CostsHistory of Blood Banking6. THE DYNAMIC LANDSCAPE OF TRANSFUSION TECHNOLOGIES & TESTSBlood Transfusion: A BackdropMassive TransfusionComplications and Risks Due to TransfusionCirculatory OverloadGraft Versus Host Disease (GVHD)Hemolytic Transfusion ReactionsIron OverloadBacterial ContaminationThrombophlebitisAllergic ReactionsAir EmbolismHyperkalaemiaChanging Role of Blood Banking Technology7. BLOOD TRANSFUSION: THE PROCESS, TESTS/TECHNOLOGIESCross MatchingBlood Donor/Recipient ScreeningBlood TypingLeukoreductionLeukocyte Reduction Specification Standards/FiltersCoombs Test8. ALTERNATIVES TO BLOOD TRANSFUSION: A REAL THREAT TO THE INDUSTRYBloodless SurgeryTherapeutic ApheresisPlasmapheresisPlateletpheresisLeukapheresisVolume ExpandersColloidsAlbuminDextransHydroxyethyl StarchCrystalloidsBlood Growth Factor Therapies - Newer Alternatives to Transfusion9. PRODUCT APPROVALS/LAUNCHESBiotest Secures EC Clearance for VihumaRoche Launches cobas m 511 Haematology AnalyserAbbott Obtains CE Mark for Alinity™ s Blood and Plasma Screening DeviceBio-Rad Secures FDA Clearance for New Blood Typing Instrument and RegentsImmucor Gets CE Mark for NEO Iris™ Automated Transfusion InstrumentImmucor's PreciseType® HEA Test Obtains FDA ApprovalFresenius Kabi Obtains FDA Approval for Aurora™ Xi Plasmapheresis SystemBD Secures FDA Clearance for BD Barricor Plasma Blood Collection TubeCerus Gains Health Canada's Approval for INTERCEPT SystemFDA Clears BD's New Plastic Blood Culture BottleFDA Approves Cerus' INTERCEPT Blood SystemBD Obtains CE Mark for Vacutainer® Barricor™ TubeBD Secures FDA and EU Clearance for BD Vacutainer® UltraTouch™ Blood Collection SetRoche Expands Blood Screening Solution Portfolio with New OfferingRoche Receives USFDA Approval for cobas TaqScreen MPX Test v2 .0 for HIV, HCV, and HBV TestsAffinity Biologicals Unveils Factor VIII Deficient, Factor IX Deficient Plasmas10. RECENT INDUSTRY ACTIVITYBiotest to Sell Select US Therapy Business Assets to ADMAKedrion Biopharma Expands into RussiaHologic to Sell Blood Screening Business to GrifolsChina Biologic Products Gets CFDA Clearance for Antithrombin III Clinical TrialChina Biologic Receives CFDA Clearance for Human Trials on Human Coagulation Factor IXTerumo Inks Distribution Agreement with B Medical SystemsCreat Group Takes Over Bio ProductsTerumo Receives Initial Funding for FDP Product from US GovernmentShire Takes Over BaxaltaLFB American Plasma and ImmunoTek BioCenters Ink AgreementGrifols Expands Plasma Therapies' Production CapacityKEDPlasma Acquires Two Plasma Collection Centers in the USCerus and LifeShare Blood Centers Ink Purchase Agreement for INTERCEPTCerus Inks Production Deal with Fresenius Kabi for INTERCEPT Blood SystemBaxter Spins Off Biopharmaceutical Business into Baxalta (US)Cerus and SunCoast Blood Bank Ink Deal for INTERCEPT Blood SystemCerus Corporation Inks Purchase Agreement with Karolinska University HospitalCerus Corporation Signs Purchase Agreement with Blood Bank of DelmarvaCanadian Blood Services Closes 3 Permanent Clinics, Terminates Bloodmobile ProgramRoche Releases Elecsys HTLV-I/II ImmunoassayChina Biologic Products Purchases Additional Stake in Guizhou Taibang Biological ProductsCommunity Blood Center Merges with New York Blood CenterCerus Corp. Partners with Kawasumi Laboratories for Developing Intercept Platelets KitsVascular Solutions Collaborates with US AMMDA to Develop Plasma Products for Treating HemorrhageThe San Diego Blood Bank Collaborates with Clinical and Translational Research InstituteAABB Collaborates with AATM for Promoting Blood and Cellular Therapies Standards in AsiabioCSL Partners with Immucor for Distributing Transfusion Technology in Australia and New ZealandPrIME Biologics Opens Plasma Fractionation Plant in Singapore11. FOCUS ON SELECT PLAYERSLeading Blood BanksAABB (USA)America's Blood Centers (USA)American Red Cross (USA)Canadian Blood Services (Canada)Japan Red Cross Society (Japan)New York Blood Center (USA)Sanquin Blood Supply Foundation (The Netherlands)Leading Players in Blood Bank Technology and SuppliesAbbott Laboratories (USA)Beckman Coulter, Inc. (USA)Becton, Dickinson and Company (USA)bioMérieux SA (France)Bio-Rad Laboratories, Inc. (USA)Cerus Corporation (USA)CSL Behring LLC (USA)Fresenius Kabi AG (Germany)Fenwal Inc. (USA)Haemonetics Corporation (USA)Immucor Inc. (USA)Kawasumi Laboratories, Inc. (Japan)MacoPharma SA (France)Ortho-Clinical Diagnostics, Inc. (USA)Terumo BCT Inc. (USA)Leading Players in Plasma FractionationBeijing Tiantan Biological Products Co., Ltd. (China)Bharat Serums and Vaccines Ltd. (India)Bio Products Laboratory Ltd. (UK)Biotest AG (Germany)China Biologic Products, Inc. (China)Grifols S.A. (Spain)Huanlan Biological Engineering Inc. (China)Kedrion S.p.A. (Italy)LFB Group (France)Octapharma AG (Switzerland)Shanghai RAAS Blood Products Co., Ltd. (China)Shire plc (Ireland)Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. (China)12. GLOBAL MARKET PERSPECTIVETable 34: World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 35: World Historic Review for Blood Banking and Blood Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 36: World 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)Blood Banking and Blood Products Market by Product Group/TypeTable 37: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 38: World Historic Review for Blood Components and Plasma Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 39: World 14-Year Perspective for Blood Components and Plasma Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)Table 40: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Product Type - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 41: World Historic Review for Blood Components and Plasma Products by Product Type - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 42: World 14-Year Perspective for Blood Components and Plasma Products by Product Type - Percentage Breakdown of Value Sales for Whole Blood & Cellular Components, and Plasma Fractions Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)Table 43: World Recent Past, Current & Future Analysis for Whole Blood & Cellular Components by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 44: World Historic Review for Whole Blood & Cellular Components by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 45: World 14-Year Perspective for Whole Blood & Cellular Components by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)Table 46: World Recent Past, Current & Future Analysis for Plasma Fractions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 47: World Historic Review for Plasma Fractions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 48: World 14-Year Perspective for Plasma Fractions by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)Table 49: World Recent Past, Current & Future Analysis for Equipment, Blood Tests and Other Consumables by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 50: World Historic Review for Equipment, Blood Tests and Other Consumables by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 51: World 14-Year Perspective for Equipment, Blood Tests and Other Consumables by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)III. MARKET1. THE UNITED STATESA.Market AnalysisCurrent and Future AnalysisDemand for Blood Transfusion WanesTable 52: US Blood and Organ Banks by Leading Players (2014): Percentage Share Breakdown of Revenues for American Red Cross, Baxter International Inc., Blood Systems, Musculoskeletal Transplant Foundation, New York Blood Center, and Others (includes corresponding Graph/Chart)Table 53: US Blood Banking Market by Leading Suppliers (2015): Percentage Breakdown of Unit Volumes for American Red Cross, Blood Centers of America, and Others (includes corresponding Graph/Chart)Table 54: American Red Cross Dominates US Blood Platelet Production (2014): Percentage Share Breakdown of Production Volume for American Red Cross, and Others (includes corresponding Graph/Chart)Blood Collection Economy Treads a TightropeLower Blood Prices Become the Order of the DayAging Baby-Boomer Demography: A Key Market DriverTable 55: North American Elderly Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)Favorable Reimbursement and High Usage Make US the Largest Consumer of Immunoglobulins WorldwideUS Blood Collection & Supply ProfileTable 56: Number of Plasma Collection Centers in the US: 2011-2015 (includes corresponding Graph/Chart)Table 57: US Plasma Collections for Years 2009, 2012 & 2015 (In Millions) (includes corresponding Graph/Chart)Blood Group DistributionTable 58: US Market for Blood Banking and Blood Products: Percentage Breakup of Blood Group by Rh Factor (includes corresponding Graph/Chart)Table 59: Percentage Breakup of Rh Blood Types in the US by Racial Group (includes corresponding Graph/Chart)US Plasma Industry Remains Highly ConcentratedTable 60: US Plasma Derivatives Market by Leading Suppliers (2015): Percentage Breakdown of Value Sales for Baxter, CSL, Grifols, and Others (includes corresponding Graph/Chart)Tough Times Ahead for IVIGApproved and Marketed Human Immunoglobulin Products in the USKey StatisticsTable 61: US Market for Immunoglobulin by Leading Players (2014): Percentage Breakdown of Value Sales for Gammagard Liquid/Kiovig, Flebogamma/Gamunex, Privigen/Carimune NF, Octagam and Others (includes corresponding Graph/Chart)Table 62: US Immunoglobulin Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Baxter Healthcare, CSL, Grifols, and Others (includes corresponding Graph/Chart)Table 63: US Market for Intravenous Immunoglobulin by Leading Player (2014): Percentage Market Share Breakdown of Volume Sales for Baxter, CSL Behring, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart)Table 64: US Market for IVIg Products by Indication (2014 & 2020P): Percentage Breakdown of Volume Sales for CIDP, CLL, ITP, MMN, PID, and Other Neurological Diseases (includes corresponding Graph/Chart)Table 65: US Specific Immunoglobulin Market by Product Type (2014): Percentage Breakdown of Value Sales for Anti-D, Anti-HB, Anti-T, and Rabies Immunoglobulin (includes corresponding Graph/Chart)Table 66: US Specific Immunoglobulin Market by Leading Players (2014): Percentage Breakdown of Value Sales for Biotest, Cangene, CSL, Grifols, Kedrion, Sanofi (includes corresponding Graph/Chart)Changing Supply Dynamics Alters Economics of Plasma ProductionTable 67: Average Price per Gram of IVIg for Europe and US Markets (includes corresponding Graph/Chart)Regulations Control Plasma Collection IndustryKey StatisticsTable 68: US Blood Bag (With Filters) Market (2014): Percentage Share Breakdown of Value Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, Terumo, and Others (includes corresponding Graph/Chart)Table 69: US Whole Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, Terumo and Others (includes corresponding Graph/Chart)Table 70: US Automated Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, and Terumo (includes corresponding Graph/Chart)Product Approvals/LaunchesStrategic Corporate DevelopmentsSelect Key PlayersB.Market AnalyticsUS Blood Components and Plasma Market Analyzed by Value SalesTable 71: US Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 72: US Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 73: US 14-Year Perspective for Blood Banking and Blood Products by Product Group/ Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)US Blood Components and Plasma Market Analyzed by Consumption in UnitsTable 74: US Recent Past, Current & Future Analysis for Blood Components and Plasma by Blood Components - Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Thousand Units for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 75: US Historic Review for Blood Components and Plasma by Blood Components - Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Thousand Units for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 76: US 14-Year Perspective for Blood Components and Plasma by Blood Components - Percentage Breakdown of Volume Consumption for Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)2. CANADAA.Market AnalysisCurrent and Future AnalysisCanada Continues to Rely on Imports to Meet Demand for Blood PlasmaBleeding Disorders - A Major Threat'CSA-Z902-04' - A Comprehensive Voluntary Blood Safety StandardProduct Launches/ApprovalsStrategic Corporate DevelopmentsCanadian Blood Services - The Major Blood BankB.Market AnalyticsTable 77: Canadian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 78: Canadian Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 79: Canadian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)3. JAPANA.Market AnalysisCurrent and Future AnalysisJapan Witnesses Surge in Imported Blood ProductsGrowing Market for Fresh Frozen PlasmaGrowing Use of Imported Albumin Based Blood ProductsThe Goal of Self-SufficiencyGraying Population to Drive Market GrowthTable 80: Japanese Elderly (65+ Years) Population for the Period 2000-2020 (includes corresponding Graph/Chart)Strategic Corporate DevelopmentSelect PlayersB.Market AnalyticsTable 81: Japanese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 82: Japanese Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 83: Japanese 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)4. EUROPEA.Market AnalysisCurrent and Future AnalysisMarket Trends and IssuesLegislations on Payment for Donation Restrict DonorsGovernment's Check on Healthcare Costs Pressurizes BCT ManufacturersPurchasing System Witnesses ModificationsAging Population to Drive Demand for IVIg ProductsTable 84: Aging Population in Europe by Geographic Region (2015E & 2020): Percentage of Elderly Individuals of Age 60 Years and Above Compared to Overall Population for Eastern Europe, Northern Europe, Southern Europe, and Western Europe (includes corresponding Graph/Chart)Table 85: European Market for Intravenous Immunoglobulin by Leading Player (2014): Percentage Market Share Breakdown of Volume Sales by Plasma Fractionators for Baxter Healthcare, Biotest, CSL Behring, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart)Overview of Blood Banking MarketCompetitive ScenarioAlpha 1 Market to Benefit from Growing CompetitionKey StatisticsTable 86: European Whole Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, MacoPharma, Terumo, and Others (includes corresponding Graph/Chart)Table 87: European Automated Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/ Fenwal, Haemonetics, Terumo, and Others (includes corresponding Graph/Chart)Challenges Exist in EU Blood and Blood Components SupplyProduct ApprovalsB.Market AnalyticsTable 88: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 89: European Historic Review for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 90: European 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)Table 91: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 92: European Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 93: European 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)Table 94: European Recent Past, Current & Future Analysis for Blood Collection Devices by Type - Manual Blood Collection, Apheresis and Autologous Devices Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 95: European Historic Review for Blood Collection Devices by Type - Manual Blood Collection, Apheresis and Autologous Devices Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 96: European 14-Year Perspective for Blood Collection Devices by Type - Percentage Breakdown of Value Sales for Manual Blood Collection, Apheresis and Autologous Devices Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)4a. FRANCEA.Market AnalysisCurrent and Future AnalysisBlood Collection and Transfusion Operations in France - An OverviewStrategic Corporate DevelopmentKey PlayersB.Market AnalyticsTable 97: French Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 98: French Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 99: French 14-Year Perspective for Blood Banking and Blood Products by Product Group/ Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)4b. GERMANYA.Market AnalysisCurrent and Future AnalysisA Peek into German Blood Transfusion Organizational Set UpProduct Approvals/LaunchesSelect PlayersB.Market AnalyticsTable 100: German Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 101: German Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 102: German 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)4c. ITALYA.Market AnalysisCurrent and Future AnalysisBlood Transfusion Operational Structure in Italy - An OverviewKedrion S.p.A. - A Leading Italian Player for Plasma FractionationB.Market AnalyticsTable 103: Italian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 104: Italian Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 105: Italian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)4d. THE UNITED KINGDOMA.Market AnalysisCurrent and Future AnalysisA Peek into UK Blood Transfusion OperationsStrategic Corporate DevelopmentBio Products Laboratory Ltd - A Leading UK Player for Plasma FractionationB.Market AnalyticsTable 106: UK Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 107: UK Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 108: UK 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)4e. SPAINA.Market AnalysisCurrent and Future AnalysisBlood Transfusion in SpainStrategic Corporate DevelopmentGrifols, S.A - A Leading Spanish Player for Plasma FractionationB.Market AnalyticsTable 109: Spanish Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 110: Spanish Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 111: Spanish 14-Year Perspective for Blood Banking and Blood Products by Product Group/ Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)4f. RUSSIAA.Market AnalysisCurrent and Future AnalysisStrategic Corporate DevelopmentB.Market AnalyticsTable 112: Russian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 113: Russian Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 114: Russian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)4g. REST OF EUROPEA.Market AnalysisCurrent and Future AnalysisProduct LaunchesStrategic Corporate DevelopmentsSelect PlayersB.Market AnalyticsTable 115: Rest of Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 116: Rest of Europe Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 117: Rest of Europe 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)5. ASIA-PACIFICA.Market AnalysisCurrent and Future AnalysisASEAN - Striding Towards Standardization of Blood SupplyB.Market AnalyticsTable 118: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 119: Asia-Pacific Historic Review for Blood Banking and Blood Products by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 120: Asia-Pacific 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for China, and Rest of Asia-Pacific Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)Table 121: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 122: Asia-Pacific Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 123: Asia-Pacific 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)5a. CHINAA.Market AnalysisA Key MarketGovernment Wakes Up to RealitiesTable 124: Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Group by Type - A, B, O, and AB (includes corresponding Graph/Chart)Table 125: Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Donor by Gender - Male and Female (includes corresponding Graph/Chart)Table 126: Chinese Blood Banking and Blood Products Market: Percentage Breakdown of Blood Donor by Age Group - 16-20, 21-30, 31-40, 41-50, 51-60, and 61-70 (includes corresponding Graph/Chart)Overview of Chinese Blood Plasma MarketAvailability of Plasma Proteins in the US and China (2015): A ComparisonTable 127: Chinese Plasma Products Market by Product Type (2015): Percentage Breakdown of Value Sales for Albumin, Hyper-immune, IVIg and Others (includes corresponding Graph/Chart)Government Exercises Strict Control Over Production, Supply and Import of Plasma-based ProductsGap in Domestic Demand and Supply of Plasma Products Persists Despite Increasing OutputTable 128: Plasma Supply, Demand, and Deficit in Chinese Market: 2008-2015 (includes corresponding Graph/Chart)Table 129: Rising Number of Plasma Collection Stations and Volume of Plasma Collection in China: 2018-2015 (includes corresponding Graph/Chart)Comparison of Average Yields for Select Plasma Based Products in China and International MarketsDeregulation and Supply Crunch to Drive Up Retail Prices of Plasma-based ProductsExpanding Medical Indications Holds Key to Boosting Market GrowthComparison of USFDA and CFDA Approved Indications for Human Albumin Therapeutic ProductsComparison of USFDA and CFDA Approved Indications for Human IVIG Therapeutic ProductsCompetitive LandscapeTable 130: Chinese Plasma Collection Stations Market by Leading Players (2014): Percentage Breakdown of Stations Owned by China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Shanghai RAAS, and Others (includes corresponding Graph/Chart)Blood Plasma Product Portfolio of Major Domestic PlayersTable 131: Chinese Plasma Collection Market by Leading Players (2014): Percentage Volume Breakdown of Plasma Collection for Anhui Tonglu, CBPO, Chengdu Rongsheng, Hualan Biological, Shanxi Kangbao, Sichuan Shuyang, and Others (includes corresponding Graph/Chart)Albumin Market in China Gains Favor of both Global and Local PlayersTable 132: Leading Players in the Chinese Albumin Market (2016): Percentage Breakdown of Approvals for Baxalta, CSL, Grifols and Others (includes corresponding Graph/Chart)IVIG - Strong Opportunities AheadDomestic Players Rule IVIG MarketTable 133: Chinese IVIG (Intravenous Immunoglobulin) Products Market by Leading Players (2016): Percentage Breakdown of Volume Sales for China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Shanghai RAAS, and Others (includes corresponding Graph/Chart)Plasma Derived Factor VIII - Nascent but Hold PotentialTable 134: Chinese Coagulation Factor VIII Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for China Biologic (CBPO), Greencross China, Hualan Biological, and Shanghai RAAS (includes corresponding Graph/Chart)Other Key StatisticsTable 135: Chinese Hepatitis B Ig Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Anhui Tonrol, China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Hunan Nanyue, Shenzhen Weiwu, Sichuan Yuanda Shuyang, and Others (includes corresponding Graph/Chart)Table 136: Chinese Rabies Ig Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Anhui Tonrol, China Biologic (CBPO), CNBG Shanghai Institute, Guangdong Shuanglin Bio-Pharmacy, Hualan Biological, Hunan Nanyue, Sichuan Yuanda Shuyang Pharmaceutical, and Others (includes corresponding Graph/Chart)Table 137: Chinese Tetanus Ig Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Anhui Tonrol, China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological , Sichuan Yuanda Shuyang Pharmaceutical, and Others (includes corresponding Graph/Chart)Table 138: Chinese Human PCC (Prothrombin Complex Concentrate) Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Hualan Biological, and Others (includes corresponding Graph/Chart)Table 139: Chinese Human Ig Market by Leading Players (2014): Percentage Breakdown of Volume Sales for China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, and Sichuan Yuanda Shuyang Pharmaceutical (includes corresponding Graph/Chart)Table 140: Chinese Human Fibrinogen Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Hualan Biological, Jiangxi Boya Bio-Pharmaceutical, Shanghai RAAS, and Others (includes corresponding Graph/Chart)Table 141: Chinese Plasma Collection Market by Leading Players (2014): Percentage Breakdown of Plasma Collection Volume for Anhui Tonglu, Chengdu Rongsheng Pharmaceutical, China Biologic (CBPO), Hualan Biological, Shanxi Kangbao Biological, Sichuan Yuanda Shuyang Pharmaceutical, and Others (includes corresponding Graph/Chart)Table 142: Chinese Plasma Market by Leading Players (2014): Percentage Breakdown of Plasma Output Volume for China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Shanghai RAAS, and Others (includes corresponding Graph/Chart)Table 143: Leading Companies in the Chinese Whole Blood Processing Market (2014): Percentage Breakdown of Volume Sales for Fresenius, Shanghai Kindly Enterprise Development Group, Terumo, WEGO and Others (includes corresponding Graph/Chart)Strategic Corporate DevelopmentsSelect Key PlayersB.Market AnalyticsTable 144: Chinese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 145: Chinese Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 146: Chinese 14-Year Perspective for Blood Banking and Blood Products by Product Group/ Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)5b. REST OF ASIA-PACIFICA.Market AnalysisCurrent and Future AnalysisPlasma Fractionation in Southeast Asia - A Focus on Current and Planned CapabilitiesOverview of Select Regional MarketsAustraliaNational Blood Supply: An OverviewRole of National Blood AuthorityMaintenance Expenditure on the RiseRed Blood Cells Demand Shows Mixed FortunesIndiaDemand for Blood Banking Equipment Market on the RiseRecent Trends in the MarketIndian Blood Banking Market Witnesses Major TransformationsMarket Growth - Influencing FactorsIncreased Awareness Drives Voluntary Blood Donations in IndiaCompetitive ScenarioIndonesiaKoreaIncreasing Overseas Opportunities for Korean Blood Plasma ProductsStrategic Corporate DevelopmentsBharat Serums And Vaccines Ltd. - A Leading Indian Player for Plasma FractionationB.Market AnalyticsTable 147: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 148: Rest of Asia-Pacific Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 149: Rest of Asia-Pacific 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)6. LATIN AMERICAA.Market AnalysisCurrent and Future AnalysisTable 150: Leading Companies in the Latin American Whole Blood Processing Market (2014): Percentage Breakdown of Volume Sales for Fresenius/Fenwal, Grifols, JP, Terumo and Others (includes corresponding Graph/Chart)B.Market AnalyticsTable 151: Latin American Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 152: Latin American Historic Review for Blood Banking and Blood Products by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 153: Latin American 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for Brazil, and Rest of Latin America Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)Table 154: Latin American Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 155: Latin American Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 156: Latin American 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)6a. BRAZILMarket AnalysisTable 157: Brazilian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales FRead the full report: http://www.reportlinker.com/p04910441/Global-Blood-Banking-and-Blood-Products-Laboratory-Equipment-and-Supplies.htmlAbout Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. http://www.reportlinker.com
__________________________Contact Clare: [email protected]
US: (339)-368-6001Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-blood-banking-and-blood-products---laboratory-equipment-and-supplies-300465105.html
SOURCE Reportlinker
